| Literature DB >> 29707256 |
Elizabeth Flood-Grady1,2, Samantha R Paige1,3, Nicki Karimipour4, Paul A Harris5, Linda B Cottler2,6, Janice L Krieger1,2,7.
Abstract
INTRODUCTION: There is a dearth of literature providing guidance on how to effectively communicate about clinical research (CR).Entities:
Keywords: Internet; Transactional model of communication; clinical research; recruitment participation
Year: 2017 PMID: 29707256 PMCID: PMC5915806 DOI: 10.1017/cts.2018.2
Source DB: PubMed Journal: J Clin Transl Sci ISSN: 2059-8661
Operational definition of the 5 variables and communication categories
| Variables | Operational definition | Category | Operational definition |
|---|---|---|---|
| Source | The institution or organization disseminating (e.g., hosting, presenting) messages and content about CR participation | CTSA | Institutional recipient of the CTSA |
| Target audience | The intended recipients of the messages and content about CR participation. We used primary and secondary to distinguish between the majority and | Investigators | Individuals who are responsible for conducting or leading the clinical research trials, such as researchers, clinicians, clinician-researchers |
| minority audiences on Web sites that included information about CR for both audiences | Participants | Individuals who will participate and enroll in clinical research studies, including patients, volunteers, healthy volunteers, prospective participants, subjects, and research subjects | |
| Message | The content about CR participation, including information presented in text and video formats or embedded as webpage links | CR recruitment FAQ | Information (e.g., studios or webinars on recruiting), resources (e.g., training opportunities, templates, core facilities), funding opportunities (e.g., pilot grants, vouchers), and services (e.g., consultations) for investigators to facilitate recruitment or increase enrollment of prospective participants into studies |
| Participant CR FAQ | Messages, resources, and educational materials designed to inform prospective participants about CR or increase participation (e.g., CR study types, how to participate). If multiple formats were present, we coded for the format used to present the information (i.e., text, video, link) | ||
| Channel | Platform(s) used to host and disseminate content or communicate about CR participation (i.e., ask | CTSA main Web site | The main, NIH/NCATS CTSA-sponsored Web site identified via the NCATS Web site |
| questions, solicit feedback) | CTSA participant Web site | The corresponding CTSA-sponsored Web site for participants with a separate, standalone URL, including StudySearch Web sites and Web site-registry combinations | |
| Email/web contact | Email account hosted by the university that included the name of the CTSA, research, recruitment, or study advocate in the address. The option to send a message through the Web site channel (e.g., submit a form or send an inquiry directly through the site) to ask questions about CR participation, to seek additional information about studies, to inquire about information on the Web site, or to request consultation/service (for investigators on main Web site) was also included in this category | ||
| Social media | Social or other digital media tools presented on the Web site and represented by icons corresponding to the various channels (e.g., Facebook, Twitter). If the site hosted a social media account but did not include the icon on the Web site, it was not included | ||
| Telephone number | Number listed to contact the CTSA to communicate verbally | ||
| Address | Physical address representing the location of the CTSA and for sending traditional, written messages | ||
| Text message | Option to receive information about research studies via text messaging | ||
| Language | The type and range of languages used to present the information (e.g., content) about CR participation on the Web sites | Type | Represented by Albanian, Arabic, Cape Verdean, Chinese, English, French, Greek, Haitian Creole, Italian, Khmer, Korean, Mandarin, Portuguese, Russian, Spanish, Vietnamese |
CR, clinical research; CTSA, Clinical and Translational Science Award; NIH, National Institutes of Health; NCATS, National Center for Advancing Translational Science.
We used a dichotomous scale to record the target audience of the Web sites and to code if messages and channels were present (1) or not present (0) on the CTSA main and participant Web sites. We did not code for language on the main CTSA Web sites.
Type and frequency of communication strategies on Clinical and Translational Science Award (CTSA) main Web sites (n=62)
| Communication strategy | n (%) |
|---|---|
| Target audience | |
| Investigators (primary) | 62 (100) |
| Participants (secondary) | 55 (88.7) |
| Messages | |
| Recruitment FAQ | |
| Yes | 62 (100) |
| No | 0 (0) |
| Participant CR FAQ | |
| Yes | 55 (88.7)* |
| No | 7 (11.3) |
| Participant CR FAQ format | |
| Text | 1 (1.6) |
| Internal link | 1 (1.6) |
| Video | 3 (4.8) |
| External link | 9 (14.5) |
| Multiple | 41 (66.1)* |
| Channels | |
| Email/web contact | |
| Yes | 62 (100) |
| No | 0 (0) |
| Social media | |
| Yes | 46 (74.2) |
| No | 16 (25.8) |
| CTSA participant Web site | |
| Yes | 18 (29) |
| No | 44 (71)* |
| Language | |
| English | 55 (100) |
| Spanish | 6 (10.9) |
| More than 2 languages | 1 (1.8) |
CR, clinical research.
*Difference is significant at p<0.001.
Percentage of n values does not equal 100; 7 (11.3%) of CTSA main Web sites did not include a Participant CR FAQ.
One Web site included select content about CR participation in 17 languages.
Operational definitions of message categories on Clinical and Translational Science Award (CTSA) participant Web sites
| Message theme | Category | Operational definition |
|---|---|---|
| Relevance | Active eligibility determination | A search box or visual representation of studies by topic area (e.g., cancer, depression) or check boxes with information for participants to select from to actively determine their eligibility to participate in studies |
| Passive eligibility determination | Text describing who is eligible to participate in a study, including what it means to be a healthy volunteer, and information about individuals traditionally underrepresented in CR (e.g., children, women, minorities) | |
| Credibility | About the Web site (and source) | Information about the institution (CTSA) hosting the Web site (e.g., number of facilities, locations, and trials hosted annually, collaborators), content users could expect to find on the Web site (e.g., listing of recruiting studies), or the process for navigating the Web site |
| Participant testimonials | Stories and brief accounts from participants describing their experiences participating in a study, enrolling in a registry, or working with research teams. Stories/testimonials in plain text or video format that were embedded directly on the Web site were included, whereas those linking to separate webpages were excluded | |
| CR process | Participant rights | Ethical procedures that occur before a study to ensure participants’ decisions to enroll and remain in a study are voluntary (e.g., informed consent) and precautions taken during to protect participants’ information or to maintain their privacy and confidentiality |
| Understanding CR | Description of CR (e.g., clinical trial vs. observational study), the goal and purpose of CR, types of studies (e.g., survey, intervention) and phases of trials (e.g., Phase 2 vs. Phase 3), or clinical procedures (e.g., standard of care vs. placebo) that occur during or as part of a study | |
| CR risks | Information that could discourage CR participation, such as the potential risk for harm (e.g., minor, severe, or other adverse outcome), medication side effects, or the potential for a treatment to be ineffective | |
| Safety | Steps in place to ensure participant’s physical safety before and during the study, including IRB review, trial supervision or what participants should do if they are injured during the study | |
| Study results | Information on the process or timeline for disseminating study results, including where (e.g., clinicaltrials.gov) and how (e.g., article links directly on the Web site) the public can gain access to findings | |
| Participation | Registry participation | Description of a university research registry, including the type of registry (e.g., disease specific or disease neutral), why and how to enroll, the process for being contacted to participate in a study, and the steps to withdraw from the registry |
| Other ways to participate | Additional, non-registry ways to participate in CR, such as information on participating in a biobank, or links to local (e.g., university pediatric registry) or national listings (e.g., clinicaltrials.gov) and registries (e.g., ResearchMatch) | |
| Appeal | Intrinsic | Addressed the internal factors that could influence a participant’s decision to enroll in a study, such as the desire to help one’s self or others, or to advance science and medicine. Messages in this category appeared in plain text and as metaphors (e.g., comparison of research participation to being a hero). Metaphors were included as part of the url (site) address, in the name of the Web site, and used throughout the Web site to explain surrounding the decision to participate in research |
| Extrinsic | Addressed the external and temporal factors that could affect an individual’s decision to participate in CR, such as transportation, finances (e.g., compensation, cost to participate), or time (e.g., study or visit length) |
CR, clinical research; IRB, Institutional Review Board.
Themes and examples of messages on Clinical and Translational Science Award (CTSA) participant Web sites (n=18)
| Message theme | Category | Example |
|---|---|---|
| Relevance | Active eligibility determination | “Find a study or topic or search by condition.” “Search for research studies using various parameters, such as age or gender.” |
| Passive eligibility determination | “Anyone can participate in research studies, including children and dependent individuals.” “Research needs healthy volunteers as well as those with medical conditions.” | |
| Credibility | About the Web site (and source) | “( |
| Participant testimonials | “My experience in 3 clinical trials has been phenomenal. Although not cured, my quality of life for the nearly 4 years since diagnosis has been excellent. The professionalism and compassion of my (physician), the nurses, and staff have been truly exceptional.” “The best part of signing up ( | |
| CR process | Participant rights | “Informed consent is the process of learning the key facts about a clinical trial before you decide whether or not to volunteer.” “Your participation in research is completely voluntary and you can change your mind at any time… Ask the study doctor to explain anything you do not understand, take time to talk about the study with those you trust. You should feel comfortable about your decision…” |
| Understanding CR | “The term, “clinical trial” can refer to a general health research study but it often refers to a specific type of study. Usually when people use the term “clinical trial” they are referring to a drug or device study.” “Research studies are done to test whether new products are safe and work against disease.” | |
| CR risks | “Clinical trials still do carry some inherent risk, as most of the research involves new medical treatments.” “Research may involve different types of risks. For a study that asks you to fill out a survey has only minor risks, such as questions that may make you uneasy. For other studies, such as taking an experimental drug, the risks can be much greater (e.g., having a bad reaction to the drug).” | |
| Safety | “Typically, a medical doctor leads a clinical trial aided by nurses and other study personnel. The person in charge of a study is called a Principal Investigator (PI)…The PI is also responsible for assuring the safety of the participants.” “All research studies that are associated with our ( | |
| Study results | “We encourage all researchers to inform their research participants about the specific study results, as a way to thank you for participating in clinical research.” “Once the study is finished, it takes additional time (usually several months) to analyze the data and write the articles that summarize the results. Many studies that are registered on clinicaltrials.gov include a summary of results within a year of study completion.” | |
| Participation | Registry participation | “Creating a volunteer profile allows you to express interest in study categories, which helps our recruitment team match you to trials for which you may be eligible.” “You can remove yourself from the registry at any time. Follow the opt-out link on Welcome page.” |
| Other ways to participate | “Find more ways to get involved with research!” Click ( | |
| Appeal | Intrinsic | “There are many reasons ( |
| Extrinsic | “Some studies offer compensation and some do not. Studies listed on ( |
CR, clinical research.
Frequencies and percentages of communication strategies on Clinical and Translational Science Award (CTSA) Participant Web sites (n=18)
| Communication strategy | n (%) |
|---|---|
| Target audience | |
| Participants (primary) | 18 (100) |
| Investigators (secondary) | 12 (66.7) |
| Message ( | |
| Active eligibility determination ( | 16 (88.9) |
| Passive eligibility determination ( | 11 (61.1) |
| About the Web site (and source) ( | 17 (94.4) |
| Participant testimonials ( | 7 (38.9) |
| Participant rights ( | 10 (55.6) |
| Understanding | 8 (44.4) |
| CR risks ( | 7 (38.9) |
| Safety ( | 6 (33.3) |
| Study results ( | 3 (16.7) |
| Search active studies ( | 16 (88.9) |
| Other ways to participate ( | 13 (72.2) |
| Registry participation ( | 8 (44.4) |
| Intrinsic ( | 16 (88.9) |
| Extrinsic ( | 7 (38.9) |
| Channel | |
| Email/web contact | 17 (94.4) |
| Phone number | 14 (77.7) |
| Social media | 9 (50) |
| Mailing address | 9 (50) |
| Text messaging | 1 (5.5) |
| Language | |
| English | 18 (100) |
| Spanish | 4 (22.2) |
| Mandarin | 1 (5.5) |
CR, clinical research.
Percentage of n values does not equal 100 as strategies were not included across all Web sites.
Message themes across Clinical and Translational Science Award (CTSA) participant Web sites (n=18)
| Participant Web site | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Message theme | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | n (%) |
| Relevance | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 18 (100) |
| Credibility | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 18 (100) |
| CR Process | x | x | x | x | x | x | x | x | x | x | 10 (55.6) | ||||||||
| Participation | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 18 (100) |
| Appeal | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | 16 (88.9) | ||
| Total | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 3 | 3 | 4 | 5 | |
CR, clinical research.
CTSA participant Web sites were assigned a random number between 1 and 18 prior to inclusion in this table.
x indicates at least 1 message type from the message theme was included on CTSA participant Web site.